| Useful Advices |
Hubs | Hubbers | Topics | Request |
| #1 in Business | Subscribe Email Print |
|
You are here: Home > Business > Business > What About Bob? Further Lessons in Implementing a Diversity Strategy |
|
Useful Advices - What About Bob? Further Lessons in Implementing a Diversity Strategy
A recent movie starring Richard Dreyfus and Bill Murray tells the story of a man desperately trying to be included as a member of his psychiatrist's family. Whenever the doctor attempted to exclude him, his family would respond by asking, "What about Bob?" In the midst of all the work relating to diversity in th According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product e workplace, one group often gets excluded. When affirmative action categories are closely examined, we find that nearly everyone is covered in some way except this group. In discussions of equity, this group is excluded. As we struggle with ways to break through the glass ceiling, they are the ones on the other side. In o ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug. Examples of combination products may in r quest to value differences, we often fail to account for and honor their differences. I speak of course of the non-immigrant, non-Hispanic, able-bodied, heterosexual, white male. (Isn't it interesting that I had to list so many qualifiers to adequately identify them?) This group is often seen as "they" as " lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together. we" attempt to get more access and power in organizations. As a black management consultant, I am constantly confronted by white males who feel that they are being attacked and maligned in today=s workplace.
White men are even given a special phrase when they are not respected, or are overlooked. It is called here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe >reverse discrimination, (a term which I use guardedly for this discussion and refuse to use in general conversation). I believe that discrimination is discrimination, no matter who is the target. If a person of color is ignored, overlooked, dismissed, disrespected, or mistreated because of color, that's discrimin d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations. Combination pro tion. If a woman, disabled person, gay or lesbian person, is treated badly because of their group identification, that's discrimination. The practice of applying the term reverse discrimination when speaking of white men implies that they are the sole perpetrators of discrimination against all the other groups. It is as t ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc ough they stand united and single-minded on one side, while all other groups (the so-called diverse people) stand on the other side. They appear isolated with the "others" pointing, taunting, and blaming them, the white male, for all their problems. And, not surprisingly, white men are feeling t easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi his isolation as never before. They feel blamed. They feel distrusted. They feel unable to voice their concerns. Think about it. If a white male starts talking about feeling discriminated against, belittled, or held back, he would be challenged and chastised by many people--and he knows it. After all, the conventional argu nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically ent says that white men have 95% of the positions of power. They are the benefactors of privilege by virtue of their alikeness and affinity with the keepers of power, and they consistently perpetuate their kind in developing and selecting the next wave of power people. So, more often than not, they choose to remain silent and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ preferring not to expose their fears, their concerns, their individual thoughts, for fear of reprisal. Meanwhile they are often forced to hear, acknowledge, and even validate the fears, concerns, and thoughts of all other groups. In most of our diversity awareness training, people are invited to share their (honest) thin ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi ing with each other. This exercise is often cathartic; people realize how much they have in common (basic needs and desires), and, conversely, they realize that all people have different life experiences that cause them to see others as they do. The point of this "listening with respect" experien ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it. Following aspects would a ce is not to seek agreement, but to seek understanding. And, it is important that all points of view be heard, acknowledged, and respected without judgment. This exercise is usually successful in getting participation from all groups except white men, for the reasons described above. It becomes necessary, therefore, to gi dd to the challenges in developing combination products: Which markets to tap where the combination products can do fairly well? Which combination prod e a special invitation to white men by first showing empathy for their position and making it OK for them to say how they feel. As a result, valuable learning is not lost. People who have held a one-sided view of white men get an opportunity to see a more complete picture and to discover ways to appreciate and work more ef cts are meaningful and rational? Which therapeutic categories to select? Which Combinations can address unmet needs of the patients? Do combin ectively with members of this group. The core message and the strength of the diversity movement is inclusiveness. Inclusiveness cannot be redefined to exclude one group. In fact, failure to deliberately include white men in the debate, the strategy, and the implementation of diversity management will lea tions increase the patient compliance? What would be the developing cost? How to tackle the risks encountered during combination product developmen d to its predictable failure. White men will respond to exclusion in natural human ways. They will ban together. They will withdraw support. They will guard the old ways. They will get even. I do not wish to paint white men as victims. They are not. But then, neither is anyone else. All groups deserve an opportunity to be t? As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel efit from a business strategy that recognizes the value of people. All groups mean all groups. We cannot afford to leave any group out. Making full use of our nation's human capital requires that we include all available talent and that we remove all barriers (including assumption of privilege) to individual achievement. ping new procedures for reviewing their safety, efficacy and quality. Professional from academic institutions, pharmaceutical industries, health care indust iversity is also about treating each individual as an individual. That includes individual white men. Any thoughtful inquiry will reveal the fact that white men are individually as different from each other as are members of all other groups. It is the ability to "manage to the individual" y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products > that is the target of most diversity management initiatives. So what must we do? The answer is simple. 1. Remember that diversity management is critical to organizational success. Everyone must be able to embrace this strategy. That only happens when everyone sees some personal benefit from th . As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de ir support. 2. Watch your terminology. Terms like "diverse people" and "reverse discrimination" need to be purged from our vocabulary. We may understand full well what they mean, but they tend to feed our subconscious mind with a vision of separateness and imply that inclusion of some elopment. They need to be wiser in analyzing the market trends and the regulatory requirements. Companies that provide selfless information through particip roups requires exclusion of others. 3. Focus on the common needs of employees and address the differences, real or perceived, that affect opportunities for any group. by James O. Rodgers, CMC tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
Related Articles:Special Day Fundraising: Fundraising Cards Getting a Federal EIN for Your Start-Up Business - One Little Form - So Many Questions Easy But Powerful Brochure Writing Tips
|